MXC at time of writing .051
CPH at time of writing .54
Both M pharma companies.
Both have market cap of 62million
What really are the differences between these two companies on the books?
Off the books.. I notice something right away CPH communicates more often then MXC does with announcments.
CPH 2017 Net loss after tax 3.5million, 2018 7.5 million
MXC 2017 8.5 million, 2018 8.8 million
CPH 2017 Revenue 9,639/ 2018 183,654
MXC 2017 120,242 / 2018 296,811
CPH 2017 Total Asset 21.6 million / 2018 17.3 million
MXC 2017 20.8 million / 2018 19.9 million
Analysis of MXC when compared to CPH
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.015(3.80%) |
Mkt cap ! $17.20M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.0¢ | $2.163K | 5.582K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4763 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 52 | 1 |
View Market Depth
| Last trade - 15.42pm 08/05/2024 (20 minute delay) ? |
| RGT (ASX) Chart |